VIKTORYA GEZALIAN: Open Payments
NPI 1073239851 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $77 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $130 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| TG Therapeutics, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: MOUNJARO, BREZTRI, BRIUMVI, TRELEGY ELLIPTA, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
